# Jatin Vadhvana, M.B.B.S. – FDA Inspection, Mar 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/jatin-vadhvana-mbbs/bfbbf9cf-7040-4945-9ddf-4a98da172fd4
Source feed: FDA_Inspections

> FDA inspection 1201274 of Jatin Vadhvana, M.B.B.S., March 31, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 50. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201274
- Company Name: Jatin Vadhvana, M.B.B.S.
- Inspection Date: 2023-03-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lori-gioia/34b9339b-0bd2-4e41-8da1-b445ad829e53)
- Phuc L. Nguyen

Company: https://www.keypedia.com/companies/jatin-vadhvana-mbbs/557e70f8-a58b-4898-98ae-8feae28674e9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
